PCI Biotech: Annual overview

April 30, 2012 05:03 ET | Source: PCI Biotech Holding ASA PCI Biotech Holding ASA

Issuers of listed transferable securities are required to provide Oslo Stock Exchange with an annual statement of information made available to the public in accordance with Stock Exchange Regulations, continuing obligations paragraph 3.6.

Attached is an annual overview for PCI Biotech Holding ASA.

Attachments

Annual overview OSE...

Annual overview Brreg...

Recommended Reading

March 16, 2026 06:57 ET | Source: PCI Biotech Holding ASA

Minutes from Extraordinary General Meeting

An extraordinary general meeting of PCI Biotech Holding ASA (“the Company”) took place today, 16 March 2026. All the matters on the agenda were approved in accordance with the proposals set out in...
Read More
February 23, 2026 07:17 ET | Source: PCI Biotech Holding ASA

Notice of Extraordinary General Meeting, proposed company dissolution and delisting

Oslo, Norway 23 February 2026 – An extraordinary general meeting of PCI Biotech Holding ASA (‘PCI Biotech’ or ‘Company’) will be held at the company’s office at Oslo Cancer Cluster Innovation Park, on...
Read More